Pliant Therapeutics (PLRX) Stock Price

$3.08 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    1

  • Technical

    2

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Pliant Therapeutics, AI stock picks, stock alerts and much more.

Sign up

PLRX AI Stock Analysis

AI stock analysis for PLRX is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Pliant Therapeutics (PLRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Pliant Therapeutics (PLRX) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Pliant Therapeutics (PLRX), currently trading at $3.08, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About PLRX

LSE

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $21.62
2%
6
INO Inovio Pharmaceuticals
INO		 $2.24
0.9%
2
MRNA Moderna
MRNA		 $35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL		 $8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO		 $36.85
0.1%
6

News

Pliant Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Pliant Therapeutics, Inc. (PLRX)
February 22, 2025. accessnewswire.com
Pliant Therapeutics, Inc. Being Investigated on Behalf of Pliant Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details

Pliant Therapeutics, Inc. Being Investigated on Behalf of Pliant Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details
February 21, 2025. accessnewswire.com
An Investigation Has Been Launched Into Pliant Therapeutics, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm

An Investigation Has Been Launched Into Pliant Therapeutics, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
February 21, 2025. accessnewswire.com
PLRX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Pliant Therapeutics, Inc. investment

PLRX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Pliant Therapeutics, Inc. investment
February 21, 2025. accessnewswire.com

PLRX Alternative Data

Web Traffic

Pliant Therapeutics receives an estimated 6989 monthly visitors to pliantrx.com.

  • Web Traffic

    6989

  • Change from Previous Month

    7%

  • 3 Month Change

    22.7%

  • YoY Change

    22.7%

News Mentions

Pliant Therapeutics was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    0%

Reddit Mentions

Pliant Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

Facebook Engagement

Pliant Therapeutics has engaged 1 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    50%

  • YoY Change

    50%

Youtube Subscribers

Pliant Therapeutics has 111 subscribers on its main Youtube channel, up by 8.8% over the last month.

  • Youtube Subscribers

    111

  • Daily Change

    0%

  • 1 Month Change

    8.8%

  • 3 Month Change

    12.1%

  • YoY Change

    12.1%

LinkedIn Followers

12,617 are following Pliant Therapeutics on LinkedIn, up by 2.1% over the last month.

  • LinkedIn Followers

    12617

  • Daily Change

    0%

  • 1 Month Change

    2.1%

  • 3 Month Change

    4.1%

Job Postings

Pliant Therapeutics has an estimated 9 open job postings, which is down -40% over the last month.

  • Job Postings

    9

  • Daily Change

    0%

  • 1 Month Change

    40%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, Pliant Therapeutics has 185 employees, down by -0.5% over the last month.

  • LinkedIn Employees

    185

  • Daily Change

    0%

  • 1 Month Change

    0.5%

  • 3 Month Change

    0.5%

  • YoY Change

    0.5%

Twitter Followers

Pliant Therapeutics has 480 Twitter Followers on its main Twitter (also known as X) account, which is up by 4.6% over the last month.

  • Twitter Followers

    480

  • Daily Change

    0.2%

  • 1 Month Change

    4.6%

  • 3 Month Change

    0.4%

  • YoY Change

    0.4%

Business Outlook

  • Business Outlook

    100

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

PLRX Financials

PLRX Key Metrics

  • Total Revenue

    $0

  • Net Income

    -$57.8M

  • Earnings per Share

    -$0.95

  • Free cash flow

    -$33.2M

  • EBITDA

    -$62M

  • EBITDA Ratio

    0

  • Total Assets

    $445.7M

PLRX 2-year Revenue & Income
PLRX 2-year Free Cash Flow

PLRX Technicals

PLRX SMA
PLRX RSI

FAQ

What's the current price of Pliant Therapeutics (PLRX) Stock?
The price of an Pliant Therapeutics (PLRX) share is $3.08.

What's the market cap of Pliant Therapeutics?
The current market cap of Pliant Therapeutics is 187.4M.

Should I buy or sell PLRX?
Pliant Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Pliant Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.

Is Pliant Therapeutics a good investment?
The current analysis of Pliant Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Pliant Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Pliant Therapeutics (PLRX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Pliant Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Pliant Therapeutics (PLRX) that investors often compare it to?
Pliant Therapeutics (PLRX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Pliant Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Pliant Therapeutics' stock price to be around $2.97 in 2026. Starting from the current price of $3.08, this represents a 3.4% change in price, indicating a neutral outlook for the stock.

How to buy Pliant Therapeutics (PLRX) Stock?
Pliant Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Pliant Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.